This study looks at the cost-effectiveness of implementing a package of care for women who experience a change in their baby’s movements.

The AFFIRM trial (which Sands contributed funding to) aimed to test whether stillbirths are reduced by an intervention that comprises promoting awareness of fetal movements among pregnant women and introducing a package of care when women report a change in movements. AFFIRM found that there were 11% fewer stillbirths after the intervention was introduced, but didn’t see the drop in mortality of a third that was predicted of the start of the trial. (A full paper, reporting the results of the AFFIRM study, will shortly be published in The Lancet.)

This study aims to assess the cost-effectiveness of the AFFIRM trial’s intervention plan, looking at the costs per stillbirth avoided in the trial and estimating the costs if the AFFIRM care package were implemented nationally. It’s important to know if the care package is cost–effective or not: if it isn’t there would be no case for implementing the AFFIRM intervention or for further research in this area. On the other hand if the answer is that it is cost effective there would be a stronger argument for further work on the AFFIRM fetal movement intervention, with this study forming part of the evidence base for implementation.



Lead Researcher: Dr Elizabeth Camacho, University of Manchester

Amount awarded: £26,892 (additional funding provided by Tommy’s)

Length of study: 6 months 

Exit Site